Cellectis SA (CLLS)
1.94
+0.07
(+3.74%)
USD |
NASDAQ |
Nov 18, 16:00
1.94
0.00 (0.00%)
After-Hours: 20:00
Cellectis Price: 1.94 for Nov. 18, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 18, 2024 | 1.90 | 1.98 | 1.83 | 1.94 | 216737.0 |
| Nov 15, 2024 | 1.91 | 1.91 | 1.77 | 1.87 | 72315.00 |
| Nov 14, 2024 | 1.96 | 1.96 | 1.86 | 1.91 | 20551.00 |
| Nov 13, 2024 | 1.93 | 2.000 | 1.91 | 1.98 | 33707.00 |
| Nov 12, 2024 | 1.94 | 1.98 | 1.87 | 1.975 | 210888.0 |
| Nov 11, 2024 | 1.77 | 1.93 | 1.77 | 1.91 | 193538.0 |
| Nov 08, 2024 | 1.81 | 1.81 | 1.73 | 1.77 | 32216.00 |
| Nov 07, 2024 | 1.76 | 1.760 | 1.70 | 1.75 | 74235.00 |
| Nov 06, 2024 | 1.88 | 1.88 | 1.745 | 1.77 | 124031.0 |
| Nov 05, 2024 | 1.90 | 1.90 | 1.78 | 1.78 | 185704.0 |
| Nov 04, 2024 | 1.80 | 1.840 | 1.75 | 1.76 | 131131.0 |
| Nov 01, 2024 | 1.80 | 1.81 | 1.775 | 1.80 | 87242.00 |
| Oct 31, 2024 | 1.874 | 1.874 | 1.78 | 1.78 | 20104.00 |
| Oct 30, 2024 | 1.83 | 1.89 | 1.77 | 1.82 | 56668.00 |
| Oct 29, 2024 | 1.956 | 1.97 | 1.80 | 1.83 | 199166.0 |
| Oct 28, 2024 | 1.86 | 1.941 | 1.86 | 1.93 | 22311.00 |
| Oct 25, 2024 | 1.922 | 1.946 | 1.80 | 1.86 | 26317.00 |
| Oct 24, 2024 | 1.92 | 2.00 | 1.85 | 1.90 | 37119.00 |
| Oct 23, 2024 | 1.83 | 1.98 | 1.78 | 1.97 | 263766.0 |
| Oct 22, 2024 | 1.85 | 1.91 | 1.78 | 1.80 | 37162.00 |
| Oct 21, 2024 | 1.94 | 1.94 | 1.83 | 1.835 | 32815.00 |
| Oct 18, 2024 | 1.96 | 1.964 | 1.90 | 1.90 | 43300.00 |
| Oct 17, 2024 | 1.95 | 1.95 | 1.88 | 1.91 | 32792.00 |
| Oct 16, 2024 | 1.93 | 1.97 | 1.89 | 1.90 | 42888.00 |
| Oct 15, 2024 | 2.02 | 2.02 | 1.89 | 1.89 | 24464.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.97
Minimum
Oct 31 2023
33.25
Maximum
Jan 19 2021
8.726
Average
3.645
Median
Price Benchmarks
| Edap TMS SA | 2.36 |
| DBV Technologies SA | 0.51 |
| Genfit SA | 4.37 |
| Adaptimmune Therapeutics PLC | 0.595 |
| Akari Therapeutics PLC | 2.29 |
Price Related Metrics
| PS Ratio | 5.979 |
| Price to Book Value | 1.500 |
| Price to Free Cash Flow | 2.879 |
| Earnings Yield | -69.07% |
| Market Cap | 194.18M |